China Jo-Jo Drugstores, Inc. (CJJD)
USD 1.82
(0.91%)
USD 1.82
(0.91%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 154.54 Million USD | 3.85% |
| 2023 | 148.81 Million USD | -9.48% |
| 2022 | 164.39 Million USD | 23.48% |
| 2021 | 133.13 Million USD | 13.47% |
| 2020 | 117.32 Million USD | 9.09% |
| 2019 | 107.55 Million USD | 11.9% |
| 2018 | 96.11 Million USD | 17.93% |
| 2017 | 81.49 Million USD | -8.5% |
| 2016 | 89.06 Million USD | 15.83% |
| 2015 | 76.89 Million USD | 16.24% |
| 2014 | 66.15 Million USD | -26.08% |
| 2013 | 89.49 Million USD | -5.15% |
| 2012 | 94.35 Million USD | 34.85% |
| 2011 | 69.96 Million USD | 26.81% |
| 2010 | 55.17 Million USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 37.98 Million USD | 0.0% |
| 2024 Q2 | 39.28 Million USD | 0.0% |
| 2024 FY | 154.54 Million USD | 3.85% |
| 2024 Q3 | 37.98 Million USD | -3.32% |
| 2024 Q1 | 39.28 Million USD | 3.27% |
| 2023 Q2 | 36.36 Million USD | 0.0% |
| 2023 Q1 | 36.36 Million USD | -57.67% |
| 2023 Q3 | 38.04 Million USD | 4.63% |
| 2023 Q4 | 38.04 Million USD | 0.0% |
| 2023 FY | 148.81 Million USD | -9.48% |
| 2022 Q2 | 78.48 Million USD | 100.0% |
| 2022 Q3 | 42.95 Million USD | -45.27% |
| 2022 Q4 | 85.9 Million USD | 100.0% |
| 2022 Q1 | 39.24 Million USD | 9.93% |
| 2022 FY | 164.39 Million USD | 23.48% |
| 2021 FY | 133.13 Million USD | 13.47% |
| 2021 Q1 | 31.05 Million USD | 2.39% |
| 2021 Q3 | 35.53 Million USD | 15.23% |
| 2021 Q4 | 35.69 Million USD | 0.45% |
| 2021 Q2 | 30.84 Million USD | -0.68% |
| 2020 FY | 117.32 Million USD | 9.09% |
| 2020 Q4 | 30.32 Million USD | -9.09% |
| 2020 Q3 | 33.36 Million USD | 17.67% |
| 2020 Q2 | 28.35 Million USD | 12.16% |
| 2020 Q1 | 25.28 Million USD | -4.43% |
| 2019 Q4 | 26.45 Million USD | -14.44% |
| 2019 Q2 | 27.4 Million USD | 20.36% |
| 2019 FY | 107.55 Million USD | 11.9% |
| 2019 Q3 | 30.91 Million USD | 12.8% |
| 2019 Q1 | 22.77 Million USD | -5.66% |
| 2018 Q2 | 23.49 Million USD | 8.4% |
| 2018 FY | 96.11 Million USD | 17.93% |
| 2018 Q1 | 21.67 Million USD | 9.49% |
| 2018 Q3 | 26.81 Million USD | 14.14% |
| 2018 Q4 | 24.13 Million USD | -9.97% |
| 2017 Q3 | 20.61 Million USD | 2.23% |
| 2017 FY | 81.49 Million USD | -8.5% |
| 2017 Q4 | 19.79 Million USD | -3.97% |
| 2017 Q2 | 20.16 Million USD | -3.7% |
| 2017 Q1 | 20.93 Million USD | 2.28% |
| 2016 Q4 | 20.46 Million USD | -17.16% |
| 2016 Q2 | 22.57 Million USD | 5.94% |
| 2016 Q3 | 24.7 Million USD | 9.44% |
| 2016 FY | 89.06 Million USD | 15.83% |
| 2016 Q1 | 21.31 Million USD | 3.09% |
| 2015 Q4 | 20.67 Million USD | -3.04% |
| 2015 Q2 | 18.44 Million USD | 12.06% |
| 2015 Q1 | 16.45 Million USD | 2.04% |
| 2015 FY | 76.89 Million USD | 16.24% |
| 2015 Q3 | 21.32 Million USD | 15.59% |
| 2014 Q2 | 16.85 Million USD | 9.9% |
| 2014 Q3 | 17.83 Million USD | 5.8% |
| 2014 Q4 | 16.12 Million USD | -9.55% |
| 2014 Q1 | 15.33 Million USD | 6.6% |
| 2014 FY | 66.15 Million USD | -26.08% |
| 2013 Q2 | 26.66 Million USD | -18.82% |
| 2013 Q4 | 14.38 Million USD | -7.75% |
| 2013 Q3 | 15.59 Million USD | -41.51% |
| 2013 Q1 | 32.84 Million USD | 31.09% |
| 2013 FY | 89.49 Million USD | -5.15% |
| 2012 Q4 | 25.05 Million USD | -2.29% |
| 2012 FY | 94.35 Million USD | 34.85% |
| 2012 Q3 | 25.64 Million USD | 15.38% |
| 2012 Q2 | 22.22 Million USD | 3.72% |
| 2012 Q1 | 21.42 Million USD | 1.84% |
| 2011 Q1 | 15.2 Million USD | -6.77% |
| 2011 Q4 | 21.04 Million USD | 16.62% |
| 2011 Q3 | 18.04 Million USD | 15.08% |
| 2011 FY | 69.96 Million USD | 26.81% |
| 2011 Q2 | 15.67 Million USD | 3.1% |
| 2010 FY | 55.17 Million USD | 0.0% |
| 2010 Q4 | 16.31 Million USD | 9.3% |
| 2010 Q2 | 12.25 Million USD | 0.0% |
| 2010 Q3 | 14.92 Million USD | 21.74% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | - USD | -Infinity% |
| BIMI International Medical Inc. | 11.83 Million USD | -1206.307% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 130.19 Million USD | -18.702% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 130.19 Million USD | -18.702% |
| Leafly Holdings, Inc. | 42.25 Million USD | -265.76% |
| Leafly Holdings, Inc. | 42.25 Million USD | -265.76% |
| LifeMD, Inc. | 152.54 Million USD | -1.307% |
| LifeMD, Inc. | 152.54 Million USD | -1.307% |
| TRxADE HEALTH, Inc. | 8.27 Million USD | -1768.195% |
| PetMed Express, Inc. | 281.06 Million USD | 45.016% |
| Walgreens Boots Alliance, Inc. | 147.65 Billion USD | 99.895% |